Oramed Pharmaceuticals Inc. – Credit Agreements

NASDAQ: ORMP
Share price (6/2/26): $3.60
Market cap (6/2/26): $147 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 10-K 5 pages Oramed Pharmaceuticals Inc. Annual Report on Form 10-K Exhibit [__].1 English Summary of Loan Agreement by and Among Oramed Ltd. and Tova Hochma Im Nachala Ltd. (As Lenders) and Project Hafasga – Telefoniot Hahadasha Ltd. (As Borrower) (Originally Executed in Hebrew) Dated March 24, 2025

from 8-K 56 pages Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement by and Among Sorrento Therapeutics, Inc. Scintilla Pharmaceuticals, Inc. as Borrowers, and Oramed Pharmaceuticals Inc., as Lender Dated as of August 9, 2023